Header Logo

PCSK9: an emerging player in cardiometabolic aging and its potential as a therapeutic target and biomarker.

PCSK9: an emerging player in cardiometabolic aging and its potential as a therapeutic target and biomarker. Geroscience. 2023 Dec 18.

View in: PubMed